Recent advances in peptide-based therapy for Type 2 diabetes and obesity

JM Conlon; PR Flatt; CJ Bailey

doi:10.1016/j.peptides.2021.170652

Recent advances in peptide-based therapy for Type 2 diabetes and obesity

JM Conlon
, PR Flatt
, CJ Bailey

Research output: Contribution to specialist publication › Editorial

1 Citation (Scopus)

40 Downloads (Pure)

Abstract

The incidence of obesity-related Type 2 diabetes mellitus (T2DM) continues to increase worldwide at an alarming rate. This editorial attempts to highlight some recent developments in the therapeutic applications of peptides for the control of glucose homeostasis and reduction in body weight in these patients.

Original language	English
Pages	170652
Volume	145
No.	170652
Specialist publication	Peptides
DOIs	https://doi.org/10.1016/j.peptides.2021.170652
Publication status	Published (in print/issue) - Nov 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/j.peptides.2021.170652Licence: CC BY-NC-ND

Editorial PEPTIDES 2021Author Accepted Manuscript, 30.9 KBLicence: CC BY-NC-ND

Cite this

@misc{7079cf55796644418aed285db175e879,

title = "Recent advances in peptide-based therapy for Type 2 diabetes and obesity",

abstract = "The incidence of obesity-related Type 2 diabetes mellitus (T2DM) continues to increase worldwide at an alarming rate. This editorial attempts to highlight some recent developments in the therapeutic applications of peptides for the control of glucose homeostasis and reduction in body weight in these patients.",

author = "JM Conlon and PR Flatt and CJ Bailey",

year = "2021",

month = nov,

doi = "10.1016/j.peptides.2021.170652",

language = "English",

volume = "145",

pages = "170652",

journal = "Peptides",

issn = "0196-9781",

publisher = "Elsevier Inc.",

}

TY - GEN

T1 - Recent advances in peptide-based therapy for Type 2 diabetes and obesity

AU - Conlon, JM

AU - Flatt, PR

AU - Bailey, CJ

PY - 2021/11

Y1 - 2021/11

N2 - The incidence of obesity-related Type 2 diabetes mellitus (T2DM) continues to increase worldwide at an alarming rate. This editorial attempts to highlight some recent developments in the therapeutic applications of peptides for the control of glucose homeostasis and reduction in body weight in these patients.

AB - The incidence of obesity-related Type 2 diabetes mellitus (T2DM) continues to increase worldwide at an alarming rate. This editorial attempts to highlight some recent developments in the therapeutic applications of peptides for the control of glucose homeostasis and reduction in body weight in these patients.

UR - https://www.scopus.com/pages/publications/85115235751

U2 - 10.1016/j.peptides.2021.170652

DO - 10.1016/j.peptides.2021.170652

M3 - Editorial

C2 - 34555424

SN - 0196-9781

VL - 145

SP - 170652

JO - Peptides

JF - Peptides

ER -

Recent advances in peptide-based therapy for Type 2 diabetes and obesity

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this